Progression of benign prostatic hyperplasia: systematic review of the placebo arms of clinical trials.

Progression of benign prostatic hyperplasia: systematic review of the placebo arms of clinical trials.

Item
http://www.wikidata.org/entity/Q37189764
Apoptotic Pathways Linked to Endocrine System as Potential Therapeutic Targets for Benign Prostatic HyperplasiaFixed-dose combination therapy with dutasteride and tamsulosin in the management of benign prostatic hyperplasiaCholesterol and benign prostate disease.Association between self-perception period of lower urinary tract symptoms and International Prostate Symptom Score: a propensity score matching studyQuality of life in patients with lower urinary tract symptoms associated with BPH: change over time in real-life practice according to treatment--the QUALIPROST study.Medical management of lower urinary tract symptoms in men with benign prostatic enlargement.Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK.Validation of supra-pubic ultrasonography for preoperative prostate volume measurement in sub-Saharan Africa.Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).Flurbiprofen alone and in combination with alfuzosin for the management of lower urinary tract symptoms.Long-term Combination Therapy With α-Blockers and 5α-Reductase Inhibitors in Benign Prostatic Hyperplasia: Patient Adherence and Causes of Withdrawal From MedicationHow much improvement is needed for a real difference of lower urinary tract symptoms after long-term combination therapy for benign prostatic hyperplasia.The effects of dutasteride and finasteride on BPH-related hospitalization, surgery and prostate cancer diagnosis: a record-linkage analysis.Initial combined treatment with anticholinergics and α-blockers for men with lower urinary tract symptoms related to BPH and overactive bladder: a prospective, randomized, multi-center, double-blind, placebo-controlled study.Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and TEffects of initial combined tamsulosin and solifenacin therapy for overactive bladder and bladder outlet obstruction secondary to benign prostatic hyperplasia: a prospective, randomized, multicenter study
P2860

Progression of benign prostatic hyperplasia: systematic review of the placebo arms of clinical trials.

Item
http://www.wikidata.org/entity/Q37189764
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Progression of benign prostati ...... acebo arms of clinical trials.
@en
Progression of benign prostati ...... acebo arms of clinical trials.
@nl
type
label
Progression of benign prostati ...... acebo arms of clinical trials.
@en
Progression of benign prostati ...... acebo arms of clinical trials.
@nl
prefLabel
Progression of benign prostati ...... acebo arms of clinical trials.
@en
Progression of benign prostati ...... acebo arms of clinical trials.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Progression of benign prostati ...... acebo arms of clinical trials.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1464-410X.2008.07717.X
P433
P478
P50
P577
P698
P921